Home | Articles
Published on:December 2015
Indian Journal of Pharmaceutical Education and Research, 2016; 50(2s):S32-S38
Pharmaceutical Research | doi:10.5530ijper.50.2.15

A Comparative Docking Studies of Dichloroacetate Analogues on Four Isozymes of Pyruvate Dehydrogenase Kinase in Humans

Authors and affiliation (s):

Masood Fereidoonnezhad1,2, Zeinab Faghih1, Ayyub Mojaddami1, Amirhossein Sakhteman1, Zahra Rezaei1*

1Department of Medicinal Chemistry and Pharmaceutical Sciences Research Centre, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, IRAN.

2Department of Medicinal Chemistry, School of Pharmacy, Ahvaz Jundishahpur University of Medical Sciences, Ahvaz, IRAN.


Introduction: The four Pyruvate dehydrogenase kinases (PDKs) that regulate the mammalian Pyruvate dehydrogenase complex (PDC) are a novel class of kinases that are expressed in most tissues. PDK is a novel therapeutic target in oncology. Recent studies show that various oncogenes or transcription factors essential for cancer development, such as loss of p53 or activation of HIF1α can induce PDK expression and therefor inhibit PDH and glucose oxidation. Dichloroacetate (DCA) is a pyruvate mimetic anti-cancer compound that stimulatethe activity of the enzyme pyruvate dehydrogenase (PDH) through inhibition of PDKs. Methods: In this study, More than 200 DCA analogues were designed. Proper docking protocols were presented for the four isoenzymes of PDK using Autodock 4.2 and Vinasoftwares. Results: The docking binding energy values were in the order of PDK2>PDK1>PDK4>PDK3. ANOVA studies shows that the P value is significant at the level of 0.05 for PDK2 compared to PDK1, PDK2 and PDK3. Conclusion: The results show that the most sensitive to DCA and its analogues was PDK2. The validity of docking procedure was proved by high values of ROCAUC or EFmax factor.

Key words: DCA analogues, Molecular docking studies, PDK isozymes, Pyruvate dehydrogenase kinase, Statistical analysis.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).


Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 0.843

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs